Harrow Stock

Harrow Div.-Adj. PEG

Dividend-Adjusted PEG Ratio of Harrow (HROW) as of Aug 15, 2026.

Div.-Adj. PEG

0.00

Last updated:

Dividend-Adjusted PEG Ratio of Harrow is 2026 0.00 . Dividend-Adjusted PEG Ratio of Harrow was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

On Eulerpool you can find the complete historical development of Dividend-Adjusted PEG Ratio Harrow since 2006 – with annual values, charts, and detailed analysis.

The dividend-adjusted PEG ratio factors in dividend yield alongside earnings growth, providing a more complete valuation for income-paying stocks.

To evaluate Dividend-Adjusted PEG Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Dividend-Adjusted PEG Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Dividend-Adjusted PEG Ratio's Harrow with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Harrow

All Key Metrics — Harrow